関連する実験動画

Updated: Feb 21, 2026

Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae
09:40

Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae

Published on: September 23, 2011

15.2K

サッキナ酸脱水原酶欠乏がん細胞は,Ym155誘発のDNA損傷に対する感受性が高まっている

Qianjin Guo1, Sooyeon Lee1, Neali Armstrong1

  • 1Department of Medicine, Division of Endocrinology, Stanford University, Stanford, CA, USA.

Endocrine-related cancer
|February 19, 2026
PubMed
まとめ

SDHB欠乏症に関連した遺伝性フェオクロモサイトーマとパラガンリオマ (hPPGL) 症候群は,転移のリスクが増加しています. 研究者らは,Ym155化学療法が,DNA損傷とROS生成を誘発することによって,SDHB欠乏がんを好ましく標的としていることを発見しました.

キーワード:
DNA損傷によるDNA損傷です.ミトコンドリアのリドックスバランスの不均衡フェオクロモサイトーマとパラガングリオマ (PPGL)デヒドロゲネーゼをサクシネートする.Ym155はYM155で,YM155はYM155で腎臓細胞癌 (Renal Cell Carcinoma) とは,腎臓細胞癌 (renal cell carcinoma) とは,腎臓細胞癌 (renal cell carcinoma) とは,腎臓細胞癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,腎臓癌 (renal cell carcinoma) とは,合成による致死性.

さらに関連する動画

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

982
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.6K

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K